Wikisage, the free encyclopedia of the second generation, is digital heritage
Topiramate: Difference between revisions
Jump to navigation
Jump to search
(pl.) |
m (→ATC) |
||
| Line 18: | Line 18: | ||
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307870/pdf/main.pdf Topiramate-induced periodic limb movement disorders in a patient affected by focal epilepsy] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307870/pdf/main.pdf Topiramate-induced periodic limb movement disorders in a patient affected by focal epilepsy] | ||
==ATC== | ==[ATC]]== | ||
<ref>https://www.whocc.no/atc_ddd_index/?code=N03AX11</ref> | <ref>https://www.whocc.no/atc_ddd_index/?code=N03AX11</ref> | ||
<references/> | <references/> | ||
[[Category:Anticonvulsants]] | [[Category:Anticonvulsants]] | ||
Revision as of 00:55, 17 October 2017
topiramate compared to phenobarbital result better effect on, both partial, generalized [1] QudexyTM is an extended release form of topiramate and could be use in patient unable to swalow intact capsules [2]
Links
Phentermine and topiramate for the management of obesity: a review
Topiramate-induced periodic limb movement disorders in a patient affected by focal epilepsy